These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4837429)

  • 21. [Immunologic specificity of accelerated skin graft rejection with antigenic overlap in the H-2 system. Role of immune lymphocytes and antibodies].
    Brondz BD
    Biull Eksp Biol Med; 1972 Dec; 73(12):61-5. PubMed ID: 4118605
    [No Abstract]   [Full Text] [Related]  

  • 22. The distribution of antibody and antibody-producing cells after immunization with xenogeneic cells.
    Harding B; MacLennan IC
    Immunology; 1972 Jul; 23(1):35-43. PubMed ID: 4558093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged survival of tumor allografts in mice pretreated with soluble transplantation antigens.
    Rosenberg EB; Hill J; Ferarri A; Herberman RB; Ting CC; Mann DL; Fahey J
    J Natl Cancer Inst; 1973 Jun; 50(6):1453-8. PubMed ID: 4717562
    [No Abstract]   [Full Text] [Related]  

  • 24. Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization.
    MacDonald HR; Phillips RA; Miller RG
    J Immunol; 1973 Aug; 111(2):565-74. PubMed ID: 4123983
    [No Abstract]   [Full Text] [Related]  

  • 25. Cell-mediated immunity and blocking antibodies to renal allografts.
    Hellström I; Hellström KE
    Transplant Proc; 1972 Sep; 4(3):369-71. PubMed ID: 4562764
    [No Abstract]   [Full Text] [Related]  

  • 26. Biological effects of heterologous antilymphocyte serum.
    Taub TN
    Prog Allergy; 1970; 14():208-58. PubMed ID: 4404047
    [No Abstract]   [Full Text] [Related]  

  • 27. The immunologic response to xenografts. Recognition of mouse H-2 histocompatibility antigens by the rat.
    Sachs DH; Winn HJ; Russell PS
    J Immunol; 1971 Aug; 107(2):481-92. PubMed ID: 4936290
    [No Abstract]   [Full Text] [Related]  

  • 28. Passive enhancement of homozygous renal allografts in the rat.
    Fabre JW; Morris PJ
    Transplantation; 1974 Nov; 18(5):429-35. PubMed ID: 4610921
    [No Abstract]   [Full Text] [Related]  

  • 29. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract]   [Full Text] [Related]  

  • 30. Preferential induction of serum blocking activity and enhancement of skin allograft by soluble alloantigen.
    Rao VS; Bonavida B; Zighelboim J; Fahey JL
    Transplantation; 1974 Jun; 17(6):568-75. PubMed ID: 4597923
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanism of allograft rejection in New Zealand mice. II. Role of a serum factor.
    Gelfand MC; Parker LM; Steinberg AD
    J Immunol; 1974 Jul; 113(1):1-8. PubMed ID: 4598887
    [No Abstract]   [Full Text] [Related]  

  • 32. Thymus-derived lymphocytes as effectors of cell-mediated immunity to syngeneic and allogeneic transplants in the rat.
    Tucker DF; Dennert G; Lennox ES
    J Immunol; 1974 Oct; 113(4):1302-12. PubMed ID: 4547337
    [No Abstract]   [Full Text] [Related]  

  • 33. Characteristics of histocompatibility barriers in congenic strains of mice. III. Passive enhancement of skin allografts in X-irradiated hosts.
    Cantrell JL; Kaliss N; Hildemann WH
    Transplantation; 1975 Feb; 19(2):95-101. PubMed ID: 1091043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-mediated reactivity and serum blocking activity in tolerant rats. Studies on ten rats operationally tolerant to skin allografts using several independent assays.
    Wright PW; Bernstein ID; Hamilton B; Gluckman JC; HELLSTROM KE
    Transplantation; 1974 Jul; 18(1):46-55. PubMed ID: 4152086
    [No Abstract]   [Full Text] [Related]  

  • 35. Cross reactivity between H-2K and H-2D products. III. Effect of H-2K-H-2D cross sensitization on skin graft survival.
    Murphy DB; Shreffler DC
    Transplantation; 1975 Jul; 20(1):38-44. PubMed ID: 52220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal autograft rejection initiated by passive transfer of immune plasma.
    Cochrum KC; Davis WC; Kountz SL; Fudenberg HH
    Transplant Proc; 1969 Mar; 1(1):301-4. PubMed ID: 4109215
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of antibody-dependent cell-mediated cytotoxicity in renal allograft rejection.
    D'Apice AJ; Morris PJ
    Transplantation; 1974 Jul; 18(1):20-6. PubMed ID: 4600073
    [No Abstract]   [Full Text] [Related]  

  • 38. A cardinal role for I-region antigens (Ia) in immunological enhancement, and the clinical implications.
    Davies DA; Staines NA
    Transplant Rev; 1976; 30():18-39. PubMed ID: 781923
    [No Abstract]   [Full Text] [Related]  

  • 39. Tolerance and enhancement in organ transplantation.
    Brent L
    Transplant Proc; 1972 Sep; 4(3):363-8. PubMed ID: 4404151
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of immunological enhancement for the growth of autochthonous tumors.
    Hellström I; Hellström KE
    Transplant Proc; 1971 Mar; 3(1):721-4. PubMed ID: 4106337
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.